WEDNESDAY, Jan. 26, 2022 (HealthDay News) — People hospitalized for COVID-19 are not necessarily out of the woods once they’re discharged: Many land in the hospital again in the months afterward, a large U.K. study finds. The researchers found that in the 10 months after leaving the hospital, COVID-19 patientsContinue Reading

THURSDAY, Jan. 20, 2022 (HealthDay News) — Having a child with type 1 diabetes can be a challenging health condition for parents to manage, but new research suggests an “artificial pancreas” system may beat standard treatment in controlling the blood sugar disease in young children. Forms of the technology —Continue Reading

MONDAY, Jan. 17, 2022 (HealthDay News) — Astronauts can develop a condition called space anemia because their bodies destroy more red blood cells than normal when in space, a groundbreaking study shows. Assessments of 14 astronauts over six months between space missions found that 54% more blood cells were destroyedContinue Reading

FRIDAY, Jan. 14, 2022 (HealthDay News) — A three-month sexual abstinence rule for blood donations from sexually active gay and bisexual men should be dropped by the U.S. Food and Drug Administration, critics urge as the country struggles with a blood shortage. Right now, based on the slight chance ofContinue Reading

MONDAY, Dec. 13, 2021 (HealthDay News) — A gene therapy that could provide a permanent cure for sickle cell disease continues to show success through a third wave of patients, researchers report. The therapy, LentiGlobin, restored normal blood function in 35 sickle cell patients who had the one-time procedure, accordingContinue Reading

TUESDAY, Nov. 23, 2021 (HealthDay News) — Folks who’ve had a clogged artery reopened probably can stop taking blood thinners sooner than previously thought, a new study argues. Patients are regularly prescribed blood thinners for a year or more after angioplasty. This is to make sure that blood doesn’t clotContinue Reading

THURSDAY, Nov. 18, 2021 (HealthDay News) — Gene therapy shows promise in reducing, and even halting, potentially life-threatening bleeding events in people with hemophilia, researchers report. Hemophilia A is the most common inherited bleeding disorder, affecting one in 5,000 males worldwide. It’s caused by a missing coagulation factor called FVIII.Continue Reading

TUESDAY, Nov. 16, 2021 (HealthDay News) — For decades, doctors have struggled with the fact that the benefit of any blood-thinning pill came with the added risk of excess bleeding. Now, an experimental anti-clotting pill called milvexian has been found to be effective in patients who had knee replacement surgeryContinue Reading